Dr Bailie, who serves as Chief Medical Advisor for Integrated Endoscopy in Irvine, California, is proud to announce the global release of the Nuvis Disposable Arthroscopy System. This product is unlike any other in the industry and will improve quality of care for hundreds of thousands of patients who have an endoscopic procedure.
Drs Llinas and Bailie To Present Original Research at the European ESSKA in Madrid Spain in November, 2019
Dr. Bailie, in conjunction with his Dr. PJ Llinas from Cali, Colombia present their original research at the European ESSKA Specialty Day meeting in Madrid Spain November 8-9, 2019.
Dr. Bailie has always had the philosophy that physicians should only use evidenced-based medicine and avoid unproven or detrimental treatment. This is true even when the treatment has been used for decades as the common “standard of care”. One example is the use of steroid injections for alleviating arthritis pain in the joint. Some physicians
It is not the cost of “healthcare” that is rising but the cost of HEALTH INSURANCE because of the need for insurance companies to maximize PROFIT OVER YOUR HEALTH.
UnitedHealth Group saw its revenue and net income increase in the second quarter of 2019, buoyed by growth in its Medicare and Optum lines. UnitedHealth recorded total revenues of $60.6 billion in the second quarter ended June 30, up 8 percent from $56.1 billion in the same quarter a year prior, according to financial documents.
Dr. Bailie Helps Integrated Endoscopy Receive FDA Approval for New Single-Use, Disposable Arthroscope
Dr. Bailie helps Integrated Endoscopy receive FDA approval for new single-use, disposable arthroscope. Click here to read more.
When active patients less than 65 years old have a massive, non-repairable rotator cuff tear and preserved function, oftentimes they are told the only option is a superior capsular reconstruction (SCR) or reverse shoulder replacement. However, Dr. Bailie and Biomet Orthopedics developed a device, which shows favorable outcomes, if performed by a surgeon experienced in
FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions
Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use The U.S. Food and Drug Administration has sent an untitled letter to R3 Stem Cell, LLC (/media/126709/download) of Scottsdale, Arizona, and its chief executive officer, David Greene, M.D. The company, through its affiliated
The Zimmer-Biomet Nano Total shoulder has now been approved by the FDA Dr. Bailie was one of the 4 surgeon-designers for this novel implant and a principal investigator in the multi-center FDA study carried out to approve the device. In fact, he was the only surgeon west of the Mississippi River selected to participate in